Delivery Order SPE2DB22D1200-SPE2DB25FM9WF

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10 mg dextroamphetamine-amphetamine tablets. The contract has a ceiling value of $2,035.68 and a period of performance ending on July 19, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,740.39 firm fixed-price delivery order is for the supply of 4,565,495,385 units of dextroamphetamine-amphetamine 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,048.80 Firm Fixed Price delivery order contract is for the supply of 4,567,198,853 units of Dextroamphetamine-Amphetamine 20 mg tablets. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $1,053.12 firm fixed-price delivery order is for 4,567,171,425 units of dextroamphetamine-amphetamine 5 mg tablets. The contract has an ultimate completion date of February 6, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,891.64 firm fixed price delivery order is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company. The order is for 4,562,001,996 units of 5 mg dextroamphetamine-amphetamine tablets, with a ceiling value of $3,161.46. The contract is a Firm Fixed Price delivery order, with an ultimate completion date of August 25, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets. The $1,363.12 Firm Fixed Price Delivery Order contract has a completion date of July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,544.86 delivery order contract is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,926.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,285,738 units of dextroamphetamine-amphetamine 15 mg tablets, with a completion date of October 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,948.98 firm fixed-price delivery order is for the supply of 4,566,953,974 units of dextroamphetamine-amphetamine 5 mg tablets. The award has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FM9WF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for dextroamphetamine-amphetamine 10 mg tablets. The contract has a ceiling value of $1,050.86 and runs through January 16, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/17/25, 8:41 AM